ARCHIVES

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

This article is from The Cancer Letter archive.

Vol. 25 No. 1 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

Oral Therapy Sorafenib Improves Survival Of Advanced Liver Cancer In Study

June 29, 2007

Continuing Resolution Expires March 27; NIH, NCI Hope For Budget Compromise

March 15, 2013

FDA, Clinical Investigators Head Or Showdown Over Demand To See Individual Patient Records

April 18, 1980

NCAB Asks Speedup Of OSP Coordinating Center Review

October 14, 1983

Oncology Societies, Cancer Center, List Reform Principles

August 12, 1994

Groups Have No Budgets As NCTN Begins Work March 1

February 28, 2014